Mulay James

CIK 00016845312 companiesDALLAS, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001684531

Recent Transactions

36 trades

Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2026-03-16$3.72/sh+654→ 654 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2026-03-16−1,310→ 3,930 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2026-03-16−654→ 654 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2026-03-16$63.50/sh−1,310→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2026-03-16$12.59/sh+1,310→ 1,310 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2026-03-16$63.50/sh−654→ 0 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2026-01-09$44.16/sh−654→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2026-01-09−10,491→ 5,240 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2026-01-09−654→ 1,308 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2026-01-09$52.99/sh−10,491→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2026-01-09$12.59/sh+10,491→ 10,491 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2026-01-09$3.72/sh+654→ 654 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-10-09$43.99/sh−5,903→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-10-09−5,903→ 1,962 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-10-09$3.72/sh+5,903→ 5,903 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-09-29−12,755→ 0 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-09-29$39.19/sh−12,755→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-09-29$1.82/sh+12,755→ 12,755 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-09-19−3,574→ 12,755 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-09-19$38.99/sh−3,574→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-09-19$1.82/sh+3,574→ 3,574 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-09-18−19,112→ 16,329 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-09-18$39.01/sh−19,112→ 0 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-09-18$1.82/sh+19,112→ 19,112 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-09-05$30.47/sh−12,342→ 14,673 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-09-05$33.22/sh−3,113→ 0 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-09-05$31.42/sh−4,095→ 10,578 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Common Stock
2025-09-05$0.60/sh+27,015→ 27,015 total
Exercise/Conversion
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-09-05−27,015→ 0 total
Sale
CG Oncology, Inc.$CGON
Common Stock
2025-09-05$32.64/sh−7,465→ 3,113 total
Award
CG Oncology, Inc.$CGON
Director Stock Option (right to buy)
2025-06-05+24,165→ 24,165 total
Award
CG Oncology, Inc.$CGON
Stock Option (Right to Buy)
2024-10-04+15,600→ 15,600 total
Award
Fulgent Genetics, Inc.$FLGT
Stock Option (Right to Buy)
2019-05-30+5,000→ 5,000 total
Award
Fulgent Genetics, Inc.$FLGT
Stock Option (Right to Buy)
2018-05-18+5,000→ 5,000 total
Award
Fulgent Genetics, Inc.$FLGT
Common Stock
2017-05-16+2,000→ 10,000 total
Award
Fulgent Genetics, Inc.$FLGT
Common Stock
2016-10-26+8,000→ 8,000 total

Companies

Recent Filings

Address

C/O CG ONCOLOGY, INC. 3000 PEGASUS PARK DRIVE, SUITE 1640

DALLAS, TX, 75247

View on SEC.gov